|
|
|
|
|
18.11.25 - 14:03
|
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India (GlobeNewswire EN)
|
|
|
SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary novel technologies to develop affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumours, announced today that it has completed with full payment the acquisition of the allogeneic gamma delta T cell technology (termed “TCB-002”) of TC BioPharm Limited (“TCBL”), a subsidiary of TC BioPharm (Holdings) PLC (OTC:TCBPY). This follows CytoMed's announcement on October 14, 2025 regarding its proposed acquisition of potentially synergistic assets from TCBL....
|
|
|
|
|
13.11.25 - 15:09
|
Flex and Merck KGaA, Darmstadt, Germany, Win 2025 PDA Drug Delivery Innovation Award (PR Newswire)
|
|
|
AUSTIN, Texas, Nov. 13, 2025/PRNewswire/ -- Flex (NASDAQ: FLEX) today announced that its Health Solutions business was awarded the prestigious 2025 PDA Drug Delivery Innovation Award for its collaboration with Merck KGaA, Darmstadt, Germany, on their connected autoinjector. The award,......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.11.25 - 14:33
|
Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that members of Wave's management team are scheduled to participate in two upcoming investor conferences in November....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
